Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Virgin Money takeover sees annual profits soar at Nationwide

(Sharecast News) - Nationwide posted a surge in annual earnings on Thursday, boosted by its £2.9bn takeover of Virgin Money. The building society, which completed the unusual takeover of the listed company in September 2024, said total underlying income in the year to 31 March was £5.2bn, up from £4.7bn a year previously.

Group net mortgage lending was £15.9bn, giving it a market share of 16.2%, up notably on 2024's 12.3%, while retail deposit balances increased by £67.3bn to £260.7bn.

As a result, statutory profits before tax jumped 30% to £2.3bn.

Debbie Crosbie, chief executive, said it had been an "outstanding" 12 months.

Group chief financial officer Muir Mathieson added: "Cost discipline is strong, with underlying Nationwide cost growth significantly below the headline level of inflation.

"Our balance sheet remains robust and well capitalised. Arrears rates are low and stable."

Looking ahead, the lender sounded a note of caution. It acknowledged that the underlying pace of UK economic activity remained "subdued" and was likely to improve "only gradually".

But it continued: "Solid labour market conditions, resilience in real earnings and lower interest rates should support housing market activity and growth in deposits.

"The global economic outlook remains highly uncertain but UK households and the UK-focused businesses we support appear generally well-placed for potential shocks."

The Virgin Money integration was also "progressing well", it noted, and had so far incurred lower-than-expected expenditure.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.